Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 166.83B | 162.42B | 157.37B | 151.53B | 146.22B |
| Total Other Revenue | 32.29B | 32.40B | 31.89B | 31.59B | 30.59B |
| Total Revenue | 199.13B | 194.82B | 189.25B | 183.12B | 176.81B |
| Cost of Revenue | 148.22B | 143.66B | 138.47B | 132.33B | 127.57B |
| Gross Profit | 50.90B | 51.16B | 50.79B | 50.79B | 49.24B |
| SG&A Expenses | 41.98B | 41.73B | 40.78B | 40.37B | 38.80B |
| Depreciation & Amortization | 628.00M | 644.00M | 604.00M | 619.00M | 580.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 190.83B | 186.03B | 179.85B | 173.32B | 166.95B |
| Operating Income | 8.30B | 8.79B | 9.41B | 9.80B | 9.86B |
| Income Before Tax | 6.71B | 7.10B | 7.07B | 7.76B | 7.90B |
| Income Tax Expenses | 1.05B | 1.57B | 1.72B | 1.86B | 1.93B |
| Earnings from Continuing Operations | 5.66K | 5.53K | 5.35K | 5.91K | 5.97K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | 5.00M | 11.00M | 11.00M | 9.00M |
| Net Income | 5.66B | 5.53B | 5.36B | 5.92B | 5.98B |
| EBIT | 8.30B | 8.79B | 9.41B | 9.80B | 9.86B |
| EBITDA | 9.84B | 10.32B | 10.89B | 11.24B | 11.26B |
| EPS Basic | 25.17 | 24.52 | 23.57 | 25.74 | 25.75 |
| Normalized Basic EPS | 19.15 | 20.51 | 22.20 | 23.24 | 23.40 |
| EPS Diluted | 25.12 | 24.46 | 23.50 | 25.63 | 25.61 |
| Normalized Diluted EPS | 19.10 | 20.46 | 22.13 | 23.14 | 23.28 |
| Average Basic Shares Outstanding | 896.70M | 906.00M | 914.60M | 921.60M | 927.90M |
| Average Diluted Shares Outstanding | 898.50M | 907.80M | 917.20M | 924.80M | 931.80M |
| Dividend Per Share | 6.84 | 6.76 | 6.68 | 6.60 | 6.52 |
| Payout Ratio | 27.00% | 27.56% | 28.40% | 25.60% | 25.22% |